What did the latest 13F filings indicate for MSGS stock?

Recent Q3 disclosures showed Quantbot reduced its stake by 52% and Gamco trimmed 1.3%. While 13Fs are backward looking, they can sway sentiment and short-term flows. We pair these signals with technicals and analyst views to gauge whether selling pressure persists or fades.

Is MSGS stock overvalued right now?

Valuation is demanding: negative EPS, Price/Sales near 7.06, and EV/Sales around 8.87. Liquidity is tight, and interest coverage is low. Bulls cite premium assets and momentum. Bears point to fundamentals. We think upside depends on clear progress toward sustained profitability and cash flow improvement.

How can Australians buy MSGS stock?

Australians can access MSGS via brokers that offer US market trading. Consider FX conversion costs, spreads, and US trading hours. Orders like limits help control slippage. There is no dividend, so it suits growth or event-driven approaches more than income strategies. Always review tax implications.

What technical levels should I watch on MSGS stock?

Key references include the 50-day near US$286.58, the Bollinger middle around US$308.96, and resistance near the upper band at US$349.50. ATR at 11.19 signals wider daily ranges. A sustained hold above US$311 may favor buyers, while a break below US$309 risks a deeper pullback.

Global Market Insights

MSGS Stock Today: March 9 — 13F Filings Flag Stake Cuts, Bullish PTs

ByDanny Kontos March 9, 2026March 9, 2026

MSGS stock is in focus after fresh 13F updates showed notable hedge fund stake cuts alongside upbeat analyst views. We break down what this means for MSGS and MSGS stock today for Australian investors. Recent data show shares at US$313.34 (5 Mar 2025), up 21.15% year to date and 58.10% over 12 months. With Q3 filings flagging Quantbot and Gamco reductions, yet seven Buy ratings versus two Holds, investors face a mixed setup ahead of the next earnings date on 1 May 2026 (UTC).